116 related articles for article (PubMed ID: 21970086)
1. Methylphenidate: growth retardation.
Prescrire Int; 2011 Oct; 20(120):238-9. PubMed ID: 21970086
[TBL] [Abstract][Full Text] [Related]
2. Does extended medication with amphetamine or methylphenidate reduce growth in hyperactive children?
Sund AM; Zeiner P
Nord J Psychiatry; 2002; 56(1):53-7. PubMed ID: 11869467
[TBL] [Abstract][Full Text] [Related]
3. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
4. Atomoxetine. Attention-deficit/hyperactivity disorder: no better than methylphenidate.
Prescrire Int; 2010 Feb; 19(105):5-8. PubMed ID: 20455329
[TBL] [Abstract][Full Text] [Related]
5. Effect of stimulants on height and weight: a review of the literature.
Faraone SV; Biederman J; Morley CP; Spencer TJ
J Am Acad Child Adolesc Psychiatry; 2008 Sep; 47(9):994-1009. PubMed ID: 18580502
[TBL] [Abstract][Full Text] [Related]
6. Stimulant treatment over 5 years: effects on growth.
Charach A; Figueroa M; Chen S; Ickowicz A; Schachar R
J Am Acad Child Adolesc Psychiatry; 2006 Apr; 45(4):415-21. PubMed ID: 16601646
[TBL] [Abstract][Full Text] [Related]
7. Attention-deficit-hyperactivity disorder: an update.
Dopheide JA; Pliszka SR
Pharmacotherapy; 2009 Jun; 29(6):656-79. PubMed ID: 19476419
[TBL] [Abstract][Full Text] [Related]
8. Impact of long-term treatment of methylphenidate on height and weight of school age children with ADHD.
Zhang H; Du M; Zhuang S
Neuropediatrics; 2010 Aug; 41(2):55-9. PubMed ID: 20799150
[TBL] [Abstract][Full Text] [Related]
9. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy.
Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H
Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014
[TBL] [Abstract][Full Text] [Related]
10. Central stimulants in the treatment of attention-deficit hyperactivity disorder (ADHD) in children and adolescents. A naturalistic study of the prescription in Sweden, 1977-2007.
Janols LO; Liliemark J; Klintberg K; von Knorring AL
Nord J Psychiatry; 2009 Nov; 63(6):508-16. PubMed ID: 19958258
[TBL] [Abstract][Full Text] [Related]
11. Long-term tolerability of the methylphenidate transdermal system in pediatric attention-deficit/hyperactivity disorder: a multicenter, prospective, 12-month, open-label, uncontrolled, phase III extension of four clinical trials.
Findling RL; Wigal SB; Bukstein OG; Boellner SW; Abikoff HB; Turnbow JM; Civil R
Clin Ther; 2009 Aug; 31(8):1844-55. PubMed ID: 19808143
[TBL] [Abstract][Full Text] [Related]
12. Comments on efficacy and tolerability of OROS methylphenidate in Korean children with attention-deficit/hyperactivity disorder.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Jun; 31(5):1149-50; author reply 1151-2. PubMed ID: 17493730
[No Abstract] [Full Text] [Related]
13. Growth deficits in ADHD children revisited: evidence for disorder-associated growth delays?
Spencer TJ; Biederman J; Harding M; O'Donnell D; Faraone SV; Wilens TE
J Am Acad Child Adolesc Psychiatry; 1996 Nov; 35(11):1460-9. PubMed ID: 8936912
[TBL] [Abstract][Full Text] [Related]
14. Methylphenidate-related growth impairment.
Holtkamp K; Peters-Wallraf B; Wüller S; Pfäaffle R; Herpertz-Dahlmann B
J Child Adolesc Psychopharmacol; 2002; 12(1):55-61. PubMed ID: 12014596
[TBL] [Abstract][Full Text] [Related]
15. Effects of methylphenidate on leptin and appetite in children with attention-deficit hyperactivity disorder: an open label trial.
Işeri E; Kiliç BG; Senol S; Karabacak NI
Methods Find Exp Clin Pharmacol; 2007; 29(1):47-52. PubMed ID: 17344944
[TBL] [Abstract][Full Text] [Related]
16. [Prescribing ritalin in combined modality management of hyperactivity with attention deficit].
Bricard C; Boidein F
Encephale; 2001; 27(5):435-43. PubMed ID: 11760693
[TBL] [Abstract][Full Text] [Related]
17. Response to growth hormone in attention deficit hyperactivity disorder: effects of methylphenidate and pemoline therapy.
Rao JK; Julius JR; Breen TJ; Blethen SL
Pediatrics; 1998 Aug; 102(2 Pt 3):497-500. PubMed ID: 9685452
[TBL] [Abstract][Full Text] [Related]
18. [Utilization of methylphenidate(Ritalin) in France].
Frances C; Hoizey G; Millart H; Trenque T
Therapie; 2002; 57(2):189-93. PubMed ID: 12185970
[TBL] [Abstract][Full Text] [Related]
19. Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial.
Kratochvil CJ; Heiligenstein JH; Dittmann R; Spencer TJ; Biederman J; Wernicke J; Newcorn JH; Casat C; Milton D; Michelson D
J Am Acad Child Adolesc Psychiatry; 2002 Jul; 41(7):776-84. PubMed ID: 12108801
[TBL] [Abstract][Full Text] [Related]
20. Neuroendocrine responses to methylphenidate and d-amphetamine: applications to attention-deficit disorder.
Lurie S; O'Quinn A
J Neuropsychiatry Clin Neurosci; 1991; 3(1):41-50. PubMed ID: 7580171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]